Cash flow Cardinal Health, Inc.

Stocks

CAH

US14149Y1082

Pharmaceuticals

Market Closed - NYSE Other stock markets 04:00:02 2026-06-12 pm EDT			5-day change	1st Jan Change
223.85 ^USD	+1.22%		+8.82%	+8.93%

Jun. 12	William O'Neil Initiates Cardinal Health at Buy	MT
May. 27	Ember LifeSciences, Inc. announced that it has received $27 million in funding from Cardinal Health, Inc., Carrier Ventures, Sea Court Capital, Amgen Ventures, TDF Ventures LLC	CI

1c4b2c65.ByXZbdShikANLTxISdotX6fN6C6bjE4sYWm4zE9qfC0.VkTrA6P2zBZ_WlsgAKtGGv2s3X2qyxdqVhnpujwESH1rHeEE5cn5M0J3dQ

Published financial data: CARDINAL HEALTH, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: June	2021	2022	2023	2024	2025
Revenues	162B	181B	205B	227B	223B
Total Revenues	162B	181B	205B	227B	223B
Cost of Goods Sold, Total	156B	175B	198B	219B	214B
Gross Profit	6.78B	6.54B	6.89B	7.41B	8.17B
Selling General & Admin Expenses, Total	4.53B	4.56B	4.83B	5B	5.38B
Amortization of Goodwill and Intangible Assets - (IS)	451M	324M	285M	268M	303M
Other Operating Expenses, Total	4.98B	4.88B	5.12B	5.27B	5.68B
Operating Income	1.79B	1.66B	1.77B	2.15B	2.48B
Interest Expense, Total	-180M	-149M	-93M	-77M	-182M
Net Interest Expenses	-180M	-149M	-93M	-77M	-182M
Currency Exchange Gains (Loss)	-8M	-	-7M	27M	-22M
Other Non Operating Income (Expenses)	55M	-16M	11M	8M	30M
EBT, Excl. Unusual Items	1.66B	1.5B	1.68B	2.1B	2.31B
Restructuring Charges	-114M	-101M	-95M	-175M	-88M
Merger & Related Restructuring Charges	-	-	-	-16M	-287M
Impairment of Goodwill	-	-2.1B	-1.2B	-675M	-
Gain (Loss) On Sale Of Investments	-2M	2M	-	-	-
Gain (Loss) On Sale Of Assets	-60M	-	-	-	-
Asset Writedown	-19M	50M	-50M	41M	-18M
Legal Settlements	-1.13B	-109M	302M	-78M	185M
Other Unusual Items	-14M	-10M	-	-	-
EBT, Incl. Unusual Items	323M	-769M	638M	1.2B	2.1B
Income Tax Expense	-289M	163M	376M	348M	532M
Earnings From Continuing Operations	612M	-932M	262M	853M	1.57B
Net Income to Company	612M	-932M	262M	853M	1.57B
Minority Interest	-1M	-1M	-1M	-1M	-8M
Net Income - (IS)	611M	-933M	261M	852M	1.56B
Net Income to Common Incl Extra Items	611M	-933M	261M	852M	1.56B
Net Income to Common Excl. Extra Items	611M	-933M	261M	852M	1.56B
Per Share Items
Net EPS - Basic	2.09	-3.34	1	3.48	6.48
Basic EPS - Continuing Operations	2.09	-3.34	1	3.48	6.48
Basic Weighted Average Shares Outstanding	292M	279M	261M	245M	241M
Net EPS - Diluted	2.08	-3.35	1	3.45	6.45
Diluted EPS - Continuing Operations	2.08	-3.35	1	3.45	6.45
Diluted Weighted Average Shares Outstanding	294M	279M	262M	247M	242M
Normalized Basic EPS	3.55	3.35	4.02	5.36	5.95
Normalized Diluted EPS	3.53	3.35	4.01	5.32	5.93
Dividend Per Share	1.95	1.97	1.99	2.01	2.03
Payout Ratio	93.78	-59.91	201.15	58.57	31.65
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	2.58B	2.36B	2.46B	2.86B	3.27B
EBITA	2.22B	1.98B	2.05B	2.41B	2.79B
EBIT	1.79B	1.66B	1.77B	2.15B	2.48B
EBITDAR	2.72B	2.49B	2.6B	3.01B	3.47B
Effective Tax Rate - (Ratio)	-89.47	-21.2	58.93	28.98	25.32
Current Domestic Taxes	-897M	63M	323M	373M	207M
Current Foreign Taxes	112M	93M	84M	79M	82M
Total Current Taxes	-785M	156M	407M	452M	289M
Deferred Domestic Taxes	511M	8M	5M	-77M	244M
Deferred Foreign Taxes	-15M	-1M	-36M	-27M	-1M
Total Deferred Taxes	496M	7M	-31M	-104M	243M
Normalized Net Income	1.04B	936M	1.05B	1.31B	1.44B
Interest Capitalized	-	-	-	-	-
Supplemental Operating Expense Items
Net Rental Expense, Total	143M	130M	133M	151M	200M
Imputed Operating Lease Interest Expense	29.52M	24.67M	17.8M	16.95M	38.59M
Imputed Operating Lease Depreciation	113M	105M	115M	134M	161M
Stock-Based Comp., SG&A Exp. (Total)	89M	81M	96M	112M	244M
Stock-Based Comp., Other (Total)	-	-	-	9M	-
Total Stock-Based Compensation	89M	81M	96M	121M	244M

Fiscal Period: June	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	3.41B	4.72B	4.04B	5.13B	3.87B
Short Term Investments	-	-	-	200M	-
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	3.41B	4.72B	4.04B	5.33B	3.87B
Accounts Receivable, Total	9.11B	10.57B	11.35B	12.1B	13.25B
Total Receivables	9.11B	10.57B	11.35B	12.1B	13.25B
Inventory	14.59B	15.64B	15.94B	14.96B	16.83B
Prepaid Expenses	2.8B	1.97B	2.32B	2.45B	2.41B
Other Current Assets, Total	1.14B	36M	172M	47M	12M
Total Current Assets	31.05B	32.94B	33.83B	34.88B	36.37B
Gross Property Plant And Equipment	6.05B	6.34B	6.75B	7.17B	8.27B
Accumulated Depreciation	-3.23B	-3.52B	-3.86B	-4.17B	-4.66B
Net Property Plant And Equipment	2.82B	2.82B	2.9B	3B	3.62B
Long-term Investments	1M	-	-	3M	14M
Goodwill	7.99B	5.86B	4.61B	4.72B	9.69B
Other Intangibles, Total	2.1B	1.77B	1.47B	1.72B	2.49B
Accounts Receivable Long-Term	56M	51M	47M	29M	25M
Deferred Tax Assets Long-Term	52M	36M	53M	72M	64M
Other Long-Term Assets, Total	382M	409M	506M	679M	853M
Total Assets	44.45B	43.88B	43.42B	45.12B	53.12B
Liabilities
Accounts Payable, Total	23.7B	27.13B	29.81B	31.76B	34.71B
Accrued Expenses, Total	2.85B	2.16B	2.43B	2.69B	2.84B
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	852M	600M	858M	401M	506M
Current Portion of Leases	124M	125M	127M	150M	208M
Other Current Liabilities	100M	535M	476M	643M	628M
Total Current Liabilities	27.62B	30.55B	33.71B	35.64B	38.9B
Long-Term Debt	5.32B	4.69B	3.85B	4.68B	7.86B
Long-Term Leases	419M	437M	434M	475M	811M
Deferred Tax Liability Non Current	2.97B	2.03B	2.1B	2.04B	2.36B
Other Non Current Liabilities	6.32B	6.88B	6.18B	5.5B	5.82B
Total Liabilities	42.66B	44.58B	46.27B	48.33B	55.76B
Common Stock, Total	2.81B	2.81B	2.75B	2.92B	2.96B
Retained Earnings	1.2B	-280M	-534M	-286M	783M
Treasury Stock	-2.19B	-3.13B	-4.91B	-5.68B	-6.36B
Comprehensive Income and Other	-34M	-114M	-151M	-167M	-155M
Total Common Equity	1.79B	-709M	-2.85B	-3.21B	-2.78B
Minority Interest	3M	3M	1M	1M	147M
Total Equity	1.79B	-706M	-2.85B	-3.21B	-2.63B
Total Liabilities And Equity	44.45B	43.88B	43.42B	45.12B	53.12B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	290M	273M	251M	244M	239M
ECS Total Common Shares Outstanding	291M	273M	251M	244M	239M
Book Value / Share	6.15	-2.6	-11.36	-13.17	-11.64
Tangible Book Value	-8.3B	-8.34B	-8.93B	-9.66B	-14.96B
Tangible Book Value Per Share	-28.53	-30.54	-35.59	-39.6	-62.59
Total Debt	6.72B	5.85B	5.27B	5.7B	9.39B
Net Debt	3.31B	1.13B	1.23B	370M	5.51B
Debt Equivalent Oper. Leases	1.14B	1.04B	1.06B	1.21B	1.6B
Minority Interest, Total (Incl. Fin. Div)	3M	3M	1M	1M	147M
Account Code - Inventory Valuation	4	4	4	4	4
LIFO Reserve, Total	565M	416M	476M	749M	-
Inventories - Others	14.78B	15.78B	16.08B	15.11B	16.96B
Land - (BS)	2.36B	1.72B	1.78B	1.88B	2.18B
Machinery, Total	3.23B	2.24B	2.33B	2.5B	2.82B
Full Time Employees	46.35K	45.57K	47.04K	47.92K	53.08K
Part Time Employees	946	930	960	978	4.62K
Accumulated Allowance for Doubtful Accounts (Supple)	242M	273M	299M	233M	213M

Fiscal Period: June	2021	2022	2023	2024	2025
Net Income	611M	-933M	261M	852M	1.56B
Depreciation & Amortization - CF	355M	381M	411M	446M	487M
Amortization of Goodwill and Intangible Assets - (CF)	428M	311M	281M	264M	303M
Depreciation & Amortization, Total	783M	692M	692M	710M	790M
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	2M	22M	7M	2M	3M
Asset Writedown & Restructuring Costs	79M	2.05B	1.25B	634M	18M
Stock-Based Compensation (CF)	89M	81M	96M	121M	244M
Provision and Write-off of Bad Debts	65M	68M	99M	36M	53M
Other Operating Activities, Total	511M	18M	-30M	-103M	251M
Change In Accounts Receivable	-904M	-1.53B	-947M	-996M	-833M
Change In Inventories	-1.58B	-1.07B	-340M	1.12B	-1.82B
Change In Accounts Payable	2.32B	3.43B	2.72B	1.82B	2.73B
Change in Other Net Operating Assets	452M	293M	-967M	-433M	-606M
Cash from Operations	2.43B	3.12B	2.84B	3.76B	2.4B
Capital Expenditure	-400M	-387M	-481M	-511M	-547M
Sale of Property, Plant, and Equipment	-	31M	12M	12M	-
Cash Acquisitions	-3M	-22M	-10M	-1.19B	-5.25B
Divestitures	-	923M	-	9M	-
Investment in Marketable and Equity Securities, Total	25M	-49M	-4M	-203M	200M
Other Investing Activities, Total	-	71M	29M	34M	4M
Cash from Investing	-378M	567M	-454M	-1.85B	-5.59B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	-	1.14B	3.67B
Total Debt Issued	-	-	-	1.14B	3.67B
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-570M	-885M	-579M	-783M	-445M
Total Debt Repaid	-570M	-885M	-579M	-783M	-445M
Issuance of Common Stock	8M	-	56M	46M	-
Repurchase of Common Stock	-200M	-1.02B	-2B	-750M	-778M
Common Dividends Paid	-573M	-559M	-525M	-499M	-494M
Common & Preferred Stock Dividends Paid	-573M	-559M	-525M	-499M	-494M
Other Financing Activities, Total	18M	-	-3M	-	-12M
Cash from Financing	-1.32B	-2.46B	-3.05B	-847M	1.94B
Foreign Exchange Rate Adjustments	11M	-25M	-8M	-9M	-3M
Miscellaneous Cash Flow Adjustments	-109M	109M	-	-	-
Net Change in Cash	636M	1.31B	-674M	1.06B	-1.26B
Supplemental Items
Cash Interest Paid	182M	153M	203M	214M	315M
Cash Income Tax Paid (Refund)	273M	-766M	156M	191M	444M
Levered Free Cash Flow	156M	3.93B	2.68B	3.96B	2.07B
Unlevered Free Cash Flow	268M	4.03B	2.74B	4.01B	2.18B
Change In Net Working Capital	1.32B	-2.6B	-1.32B	-2.35B	-146M
Net Debt Issued / Repaid	-570M	-885M	-579M	356M	3.22B

Fiscal Period: June	2021	2022	2023	2024	2025
Profitability
Return on Assets	2.63	2.35	2.53	3.03	3.16
Return on Total Capital	12.79	15.24	29.27	55.85	33.57
Return On Equity %	34.13	-171.32	-14.73	-27.65	-53.68
Return on Common Equity	34.13	-172.46	-14.66	-27.61	-52.09
Margin Analysis
Gross Profit Margin %	4.17	3.61	3.36	3.27	3.67
SG&A Margin	2.79	2.51	2.36	2.2	2.42
EBITDA Margin %	1.59	1.3	1.2	1.26	1.47
EBITA Margin %	1.37	1.09	1	1.06	1.25
EBIT Margin %	1.1	0.92	0.86	0.95	1.12
Income From Continuing Operations Margin %	0.38	-0.51	0.13	0.38	0.7
Net Income Margin %	0.38	-0.51	0.13	0.38	0.7
Net Avail. For Common Margin %	0.38	-0.51	0.13	0.38	0.7
Normalized Net Income Margin	0.64	0.52	0.51	0.58	0.64
Levered Free Cash Flow Margin	0.1	2.17	1.31	1.75	0.93
Unlevered Free Cash Flow Margin	0.17	2.22	1.34	1.77	0.98
Asset Turnover
Asset Turnover	3.81	4.11	4.7	5.13	4.53
Fixed Assets Turnover	57.9	64.34	71.75	76.89	67.24
Receivables Turnover (Average Receivables)	18.69	18.43	18.7	19.54	17.56
Inventory Turnover (Average Inventory)	11.2	11.57	12.55	14.12	13.49
Short Term Liquidity
Current Ratio	1.12	1.08	1	0.98	0.94
Quick Ratio	0.45	0.5	0.46	0.49	0.44
Operating Cash Flow to Current Liabilities	0.09	0.1	0.08	0.11	0.06
Days Sales Outstanding (Average Receivables)	19.53	19.81	19.52	18.73	20.78
Days Outstanding Inventory (Average Inventory)	32.58	31.56	29.09	25.92	27.06
Average Days Payable Outstanding	52.37	52.75	52.37	51.73	56.09
Cash Conversion Cycle (Average Days)	-0.26	-1.38	-3.77	-7.08	-8.25
Long Term Solvency
Total Debt/Equity	374.3	-828.33	-184.81	-177.55	-356.42
Total Debt / Total Capital	78.92	113.73	217.91	228.94	139
LT Debt/Equity	319.9	-725.64	-150.26	-160.4	-329.31
Long-Term Debt / Total Capital	67.45	99.63	177.17	206.82	128.43
Total Liabilities / Total Assets	95.96	101.61	106.57	107.12	104.96
EBIT / Interest Expense	9.97	11.17	19.03	27.87	13.64
EBITDA / Interest Expense	15.11	16.68	27.9	39.05	19.08
(EBITDA - Capex) / Interest Expense	12.89	14.09	22.73	32.42	16.08
Total Debt / EBITDA	2.47	2.35	2.03	1.9	2.7
Net Debt / EBITDA	1.22	0.45	0.47	0.12	1.59
Total Debt / (EBITDA - Capex)	2.89	2.79	2.49	2.28	3.21
Net Debt / (EBITDA - Capex)	1.43	0.54	0.58	0.15	1.88
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	6.24	11.63	13.04	10.66	-1.87
Gross Profit, 1 Yr. Growth %	-1.31	-3.44	5.26	7.86	10.17
EBITDA, 1 Yr. Growth %	-4.02	-8.58	4.5	15.11	14.44
EBITA, 1 Yr. Growth %	-2.71	-11.12	3.85	16.43	15.41
EBIT, 1 Yr. Growth %	1.24	-7.25	6.37	19.96	15.49
Earnings From Cont. Operations, 1 Yr. Growth %	-116.57	-252.29	-128.11	157.7	83.94
Net Income, 1 Yr. Growth %	-116.53	-252.7	-127.97	158.18	83.22
Normalized Net Income, 1 Yr. Growth %	8.44	-9.76	12.15	23.79	9.01
Diluted EPS Before Extra, 1 Yr. Growth %	-116.49	-261.06	-129.85	173.81	86.96
Accounts Receivable, 1 Yr. Growth %	10.08	16.06	7.38	8.82	9.51
Inventory, 1 Yr. Growth %	10.58	7.14	1.94	-7.21	12.53
Net Property, Plant and Equip., 1 Yr. Growth %	1	-0.07	2.8	3.73	20.37
Total Assets, 1 Yr. Growth %	9.04	-1.29	-1.05	4.09	17.73
Tangible Book Value, 1 Yr. Growth %	-12.47	0.42	7.14	6.86	54.8
Common Equity, 1 Yr. Growth %	0.11	-139.59	302.26	8.62	-13.45
Cash From Operations, 1 Yr. Growth %	23.93	28.53	-9.06	32.28	-36.28
Capital Expenditures, 1 Yr. Growth %	6.67	-3.25	24.29	6.24	7.04
Levered Free Cash Flow, 1 Yr. Growth %	-89.46	2.43K	-31.88	34.09	-47.79
Unlevered Free Cash Flow, 1 Yr. Growth %	-83.51	1.4K	-32.01	33.51	-45.58
Dividend Per Share, 1 Yr. Growth %	1.48	1.01	1.41	0.99	1
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.66	8.9	12.33	11.85	4.2
Gross Profit, 2 Yr. CAGR %	-0.41	-2.38	0.82	6.93	9.01
EBITDA, 2 Yr. CAGR %	-2.9	-6.33	-2.26	10.48	14.86
EBITA, 2 Yr. CAGR %	-0.93	-7.01	-3.92	10.92	16.01
EBIT, 2 Yr. CAGR %	1.74	-3.1	-0.67	14.11	17.81
Earnings From Cont. Operations, 2 Yr. CAGR %	-33.04	-49.76	-34.57	-4.59	117.72
Net Income, 2 Yr. CAGR %	-33.05	-49.76	-34.64	-4.69	117.49
Normalized Net Income, 2 Yr. CAGR %	8.07	-1.08	0.6	19.29	16.27
Diluted EPS Before Extra, 2 Yr. CAGR %	-32.24	-48.47	-30.66	1.18	126.25
Accounts Receivable, 2 Yr. CAGR %	3.77	13.03	11.63	6.97	9.17
Inventory, 2 Yr. CAGR %	6.69	8.84	4.51	-2.2	2.18
Net Property, Plant and Equip., 2 Yr. CAGR %	9.4	0.46	1.36	3.25	11.74
Total Assets, 2 Yr. CAGR %	4.17	3.75	-1.17	1.41	10.7
Tangible Book Value, 2 Yr. CAGR %	23.09	-6.25	3.72	7.65	28.61
Common Equity, 2 Yr. CAGR %	-46.8	-37.05	26.19	112.88	-3.04
Cash From Operations, 2 Yr. CAGR %	-5.54	26.21	8.11	8.85	-8.19
Capital Expenditures, 2 Yr. CAGR %	10.43	1.59	9.66	14.91	6.64
Levered Free Cash Flow, 2 Yr. CAGR %	-77.19	63.14	314.75	0.51	-16.25
Unlevered Free Cash Flow, 2 Yr. CAGR %	-70.94	57.33	219.44	-0.05	-14.73
Dividend Per Share, 2 Yr. CAGR %	1	1.24	1.22	0.99	1
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.9	7.61	10.26	11.77	7.07
Gross Profit, 3 Yr. CAGR %	-1.91	-1.43	0.1	3.03	8
EBITDA, 3 Yr. CAGR %	-5.12	-4.83	-2.85	3.49	11.83
EBITA, 3 Yr. CAGR %	-4.6	-4.45	-3.52	2.74	12.46
EBIT, 3 Yr. CAGR %	-3.32	-1.35	-0.04	6.15	14.64
Earnings From Cont. Operations, 3 Yr. CAGR %	33.19	-11.94	-58.6	11.7	18.75
Net Income, 3 Yr. CAGR %	33.64	-11.87	-58.67	11.72	18.5
Normalized Net Income, 3 Yr. CAGR %	0.63	1.77	3.15	8.21	15.83
Diluted EPS Before Extra, 3 Yr. CAGR %	36.94	-9.57	-57.04	18.37	24.16
Accounts Receivable, 3 Yr. CAGR %	5.19	7.71	11.11	9.92	7.81
Inventory, 3 Yr. CAGR %	5.84	6.84	6.49	0.82	2.49
Net Property, Plant and Equip., 3 Yr. CAGR %	4.28	6.15	1.24	2.13	8.67
Total Assets, 3 Yr. CAGR %	3.62	2.32	2.12	0.5	6.58
Tangible Book Value, 3 Yr. CAGR %	10.4	15.02	-1.98	5.19	21.51
Common Equity, 3 Yr. CAGR %	-33.39	-51.79	16.82	21.51	57.71
Cash From Operations, 3 Yr. CAGR %	-4.26	4.68	13.15	15.7	-8.94
Capital Expenditures, 3 Yr. CAGR %	1.37	5.67	8.65	8.51	12.23
Levered Free Cash Flow, 3 Yr. CAGR %	-60.06	9.54	21.94	194.15	-19.19
Unlevered Free Cash Flow, 3 Yr. CAGR %	-53.39	8.22	18.95	146.39	-18.36
Dividend Per Share, 3 Yr. CAGR %	1.5	1	1.16	1.14	1
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.98	6.89	8.43	9.28	7.8
Gross Profit, 5 Yr. CAGR %	0.71	0	-0.83	1.64	3.53
EBITDA, 5 Yr. CAGR %	-3.38	-4.77	-3.98	0.88	4.04
EBITA, 5 Yr. CAGR %	-4.35	-5.96	-4.33	1.26	4.05
EBIT, 5 Yr. CAGR %	-5.81	-6.2	-2.27	4.37	6.98
Earnings From Cont. Operations, 5 Yr. CAGR %	-15.62	-6.35	0.23	-8.97	-15.73
Net Income, 5 Yr. CAGR %	-15.6	-6.25	0.39	-8.97	-15.83
Normalized Net Income, 5 Yr. CAGR %	-5.74	-6.41	0.62	8.15	8.46
Diluted EPS Before Extra, 5 Yr. CAGR %	-13.6	-3.63	4.3	-5.3	-12.55
Accounts Receivable, 5 Yr. CAGR %	4.14	5.47	7.72	7.42	9.87
Inventory, 5 Yr. CAGR %	6.57	6.71	5.31	3.13	4.98
Net Property, Plant and Equip., 5 Yr. CAGR %	9.44	8.44	3.1	4.98	5.31
Total Assets, 5 Yr. CAGR %	5.43	1.81	1.68	1.95	5.44
Tangible Book Value, 5 Yr. CAGR %	23.65	28.29	7.68	12.01	9.54
Common Equity, 5 Yr. CAGR %	-22.85	-36.39	-13.99	-12.68	9.22
Cash From Operations, 5 Yr. CAGR %	-3.95	21.4	0.51	6.69	4.11
Capital Expenditures, 5 Yr. CAGR %	-2.97	0	4.61	9.27	7.84
Levered Free Cash Flow, 5 Yr. CAGR %	-35.33	43.64	1.85	5.79	6.98
Unlevered Free Cash Flow, 5 Yr. CAGR %	-29.02	39.25	0.65	4.78	6.08
Dividend Per Share, 5 Yr. CAGR %	3.89	1.7	1.3	1	1.1